Sacubitril/valsartan therapy is associated with decrease of pulse wave velocity in stable patients with heart failure with reduced ejection fraction

Objective: Dual neprilysin inhibition and angiotensin receptor blockade with LCZ696 has been shown therapeutic benefits in chronic heart failure (CHF) patients. The aim of the study was to assess sacubitril/valsartan effects on parameters of arterial stiffness in stable heart failure with reduced ejection fraction (HFrEF).
Source: Artery Research - Category: Cardiology Authors: Source Type: research